John M. Brenna joined the ranks of former Trex executives to land with other imaging companies when Computerized Thermal Imaging (CTI) announced his appointment as an executive vice president.Hologic purchased Trex from Thermo Electron in September for
John M. Brenna joined the ranks of former Trex executives to land with other imaging companies when Computerized Thermal Imaging (CTI) announced his appointment as an executive vice president.
Hologic purchased Trex from Thermo Electron in September for $55 million (SCAN, 9/27/00). Absorption of the Trex technology gave Hologic an entrée to the breast imaging sector. Brenna was president and chief operating officer of the Lorad division of Trex, which specializes in breast imaging and stereotactic biopsy systems.
CTI has been developing a breast cancer imaging system designed to recognize and differentiate temperature patterns of malignant and benign breast tumors without radiation. The CTI system consists of a patient table and heat-sensitive camera, and can be used in conjunction with traditional x-ray mammography.
The company sold 10 of its breast-imaging systems in July to a Mexico City-based company that it partly owns. The new device approval process is less stringent in Mexico than in the U.S. (SCAN, 7/5/00). The technology has been slowly moving through the FDA's premarket approval process over the past year.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.